Global Radioimmunotherapy Market Research Report 2024

SKU ID : QYR-26892063 | Publishing Date : 27-Feb-2024 | No. of pages : 91

Request a free Sample

Detailed TOC of Global Radioimmunotherapy Market Research Report 2024

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Radioimmunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Beta-emitting
        1.2.3 Targeted Alpha Therapy
    1.3 Market by Application
        1.3.1 Global Radioimmunotherapy Market Growth by Application: 2019 VS 2023 VS 2030
        1.3.2 Solid Tumor
        1.3.3 Non Hodgkin Lymphoma
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Radioimmunotherapy Market Perspective (2019-2030)
    2.2 Radioimmunotherapy Growth Trends by Region
        2.2.1 Global Radioimmunotherapy Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Radioimmunotherapy Historic Market Size by Region (2019-2024)
        2.2.3 Radioimmunotherapy Forecasted Market Size by Region (2025-2030)
    2.3 Radioimmunotherapy Market Dynamics
        2.3.1 Radioimmunotherapy Industry Trends
        2.3.2 Radioimmunotherapy Market Drivers
        2.3.3 Radioimmunotherapy Market Challenges
        2.3.4 Radioimmunotherapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Radioimmunotherapy Players by Revenue
        3.1.1 Global Top Radioimmunotherapy Players by Revenue (2019-2024)
        3.1.2 Global Radioimmunotherapy Revenue Market Share by Players (2019-2024)
    3.2 Global Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Radioimmunotherapy Revenue
    3.4 Global Radioimmunotherapy Market Concentration Ratio
        3.4.1 Global Radioimmunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Radioimmunotherapy Revenue in 2023
    3.5 Radioimmunotherapy Key Players Head office and Area Served
    3.6 Key Players Radioimmunotherapy Product Solution and Service
    3.7 Date of Enter into Radioimmunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Radioimmunotherapy Breakdown Data by Type
    4.1 Global Radioimmunotherapy Historic Market Size by Type (2019-2024)
    4.2 Global Radioimmunotherapy Forecasted Market Size by Type (2025-2030)
5 Radioimmunotherapy Breakdown Data by Application
    5.1 Global Radioimmunotherapy Historic Market Size by Application (2019-2024)
    5.2 Global Radioimmunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
    6.1 North America Radioimmunotherapy Market Size (2019-2030)
    6.2 North America Radioimmunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
    6.3 North America Radioimmunotherapy Market Size by Country (2019-2024)
    6.4 North America Radioimmunotherapy Market Size by Country (2025-2030)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Radioimmunotherapy Market Size (2019-2030)
    7.2 Europe Radioimmunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
    7.3 Europe Radioimmunotherapy Market Size by Country (2019-2024)
    7.4 Europe Radioimmunotherapy Market Size by Country (2025-2030)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Radioimmunotherapy Market Size (2019-2030)
    8.2 Asia-Pacific Radioimmunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
    8.3 Asia-Pacific Radioimmunotherapy Market Size by Region (2019-2024)
    8.4 Asia-Pacific Radioimmunotherapy Market Size by Region (2025-2030)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Radioimmunotherapy Market Size (2019-2030)
    9.2 Latin America Radioimmunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
    9.3 Latin America Radioimmunotherapy Market Size by Country (2019-2024)
    9.4 Latin America Radioimmunotherapy Market Size by Country (2025-2030)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Radioimmunotherapy Market Size (2019-2030)
    10.2 Middle East & Africa Radioimmunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
    10.3 Middle East & Africa Radioimmunotherapy Market Size by Country (2019-2024)
    10.4 Middle East & Africa Radioimmunotherapy Market Size by Country (2025-2030)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Detail
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Radioimmunotherapy Introduction
        11.1.4 Bayer Revenue in Radioimmunotherapy Business (2019-2024)
        11.1.5 Bayer Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Radioimmunotherapy Introduction
        11.2.4 Novartis Revenue in Radioimmunotherapy Business (2019-2024)
        11.2.5 Novartis Recent Development
    11.3 Lantheus
        11.3.1 Lantheus Company Detail
        11.3.2 Lantheus Business Overview
        11.3.3 Lantheus Radioimmunotherapy Introduction
        11.3.4 Lantheus Revenue in Radioimmunotherapy Business (2019-2024)
        11.3.5 Lantheus Recent Development
    11.4 Aurobindo Pharma
        11.4.1 Aurobindo Pharma Company Detail
        11.4.2 Aurobindo Pharma Business Overview
        11.4.3 Aurobindo Pharma Radioimmunotherapy Introduction
        11.4.4 Aurobindo Pharma Revenue in Radioimmunotherapy Business (2019-2024)
        11.4.5 Aurobindo Pharma Recent Development
    11.5 Mundipharma
        11.5.1 Mundipharma Company Detail
        11.5.2 Mundipharma Business Overview
        11.5.3 Mundipharma Radioimmunotherapy Introduction
        11.5.4 Mundipharma Revenue in Radioimmunotherapy Business (2019-2024)
        11.5.5 Mundipharma Recent Development
    11.6 China Isotope & Radiation
        11.6.1 China Isotope & Radiation Company Detail
        11.6.2 China Isotope & Radiation Business Overview
        11.6.3 China Isotope & Radiation Radioimmunotherapy Introduction
        11.6.4 China Isotope & Radiation Revenue in Radioimmunotherapy Business (2019-2024)
        11.6.5 China Isotope & Radiation Recent Development
    11.7 Curium Pharmaceuticals
        11.7.1 Curium Pharmaceuticals Company Detail
        11.7.2 Curium Pharmaceuticals Business Overview
        11.7.3 Curium Pharmaceuticals Radioimmunotherapy Introduction
        11.7.4 Curium Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024)
        11.7.5 Curium Pharmaceuticals Recent Development
    11.8 Gilead Sciences
        11.8.1 Gilead Sciences Company Detail
        11.8.2 Gilead Sciences Business Overview
        11.8.3 Gilead Sciences Radioimmunotherapy Introduction
        11.8.4 Gilead Sciences Revenue in Radioimmunotherapy Business (2019-2024)
        11.8.5 Gilead Sciences Recent Development
    11.9 Clarity Pharmaceuticals
        11.9.1 Clarity Pharmaceuticals Company Detail
        11.9.2 Clarity Pharmaceuticals Business Overview
        11.9.3 Clarity Pharmaceuticals Radioimmunotherapy Introduction
        11.9.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024)
        11.9.5 Clarity Pharmaceuticals Recent Development
    11.10 Curasight
        11.10.1 Curasight Company Detail
        11.10.2 Curasight Business Overview
        11.10.3 Curasight Radioimmunotherapy Introduction
        11.10.4 Curasight Revenue in Radioimmunotherapy Business (2019-2024)
        11.10.5 Curasight Recent Development
    11.11 Nordic Nanovector
        11.11.1 Nordic Nanovector Company Detail
        11.11.2 Nordic Nanovector Business Overview
        11.11.3 Nordic Nanovector Radioimmunotherapy Introduction
        11.11.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2019-2024)
        11.11.5 Nordic Nanovector Recent Development
    11.12 Philogen
        11.12.1 Philogen Company Detail
        11.12.2 Philogen Business Overview
        11.12.3 Philogen Radioimmunotherapy Introduction
        11.12.4 Philogen Revenue in Radioimmunotherapy Business (2019-2024)
        11.12.5 Philogen Recent Development
    11.13 RadioMedix
        11.13.1 RadioMedix Company Detail
        11.13.2 RadioMedix Business Overview
        11.13.3 RadioMedix Radioimmunotherapy Introduction
        11.13.4 RadioMedix Revenue in Radioimmunotherapy Business (2019-2024)
        11.13.5 RadioMedix Recent Development
    11.14 Telix Pharmaceuticals
        11.14.1 Telix Pharmaceuticals Company Detail
        11.14.2 Telix Pharmaceuticals Business Overview
        11.14.3 Telix Pharmaceuticals Radioimmunotherapy Introduction
        11.14.4 Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024)
        11.14.5 Telix Pharmaceuticals Recent Development
    11.15 Orano Med
        11.15.1 Orano Med Company Detail
        11.15.2 Orano Med Business Overview
        11.15.3 Orano Med Radioimmunotherapy Introduction
        11.15.4 Orano Med Revenue in Radioimmunotherapy Business (2019-2024)
        11.15.5 Orano Med Recent Development
    11.16 Actinium Pharmaceuticals
        11.16.1 Actinium Pharmaceuticals Company Detail
        11.16.2 Actinium Pharmaceuticals Business Overview
        11.16.3 Actinium Pharmaceuticals Radioimmunotherapy Introduction
        11.16.4 Actinium Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024)
        11.16.5 Actinium Pharmaceuticals Recent Development
    11.17 Y-mAbs Therapeutics
        11.17.1 Y-mAbs Therapeutics Company Detail
        11.17.2 Y-mAbs Therapeutics Business Overview
        11.17.3 Y-mAbs Therapeutics Radioimmunotherapy Introduction
        11.17.4 Y-mAbs Therapeutics Revenue in Radioimmunotherapy Business (2019-2024)
        11.17.5 Y-mAbs Therapeutics Recent Development
    11.18 Fusion Pharmaceuticals
        11.18.1 Fusion Pharmaceuticals Company Detail
        11.18.2 Fusion Pharmaceuticals Business Overview
        11.18.3 Fusion Pharmaceuticals Radioimmunotherapy Introduction
        11.18.4 Fusion Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024)
        11.18.5 Fusion Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Radioimmunotherapy Market Research Report 2024

List of Tables
    Table 1. Global Radioimmunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Beta-emitting
    Table 3. Key Players of Targeted Alpha Therapy
    Table 4. Global Radioimmunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Radioimmunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Radioimmunotherapy Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Radioimmunotherapy Market Share by Region (2019-2024)
    Table 8. Global Radioimmunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Radioimmunotherapy Market Share by Region (2025-2030)
    Table 10. Radioimmunotherapy Market Trends
    Table 11. Radioimmunotherapy Market Drivers
    Table 12. Radioimmunotherapy Market Challenges
    Table 13. Radioimmunotherapy Market Restraints
    Table 14. Global Radioimmunotherapy Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Radioimmunotherapy Market Share by Players (2019-2024)
    Table 16. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2023)
    Table 17. Ranking of Global Top Radioimmunotherapy Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Radioimmunotherapy Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Radioimmunotherapy Product Solution and Service
    Table 21. Date of Enter into Radioimmunotherapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Radioimmunotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Radioimmunotherapy Revenue Market Share by Type (2019-2024)
    Table 25. Global Radioimmunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Radioimmunotherapy Revenue Market Share by Type (2025-2030)
    Table 27. Global Radioimmunotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Radioimmunotherapy Revenue Market Share by Application (2019-2024)
    Table 29. Global Radioimmunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Radioimmunotherapy Revenue Market Share by Application (2025-2030)
    Table 31. North America Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Radioimmunotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Radioimmunotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Radioimmunotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Radioimmunotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Radioimmunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Radioimmunotherapy Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Radioimmunotherapy Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Radioimmunotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Radioimmunotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Radioimmunotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Radioimmunotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Bayer Company Detail
    Table 47. Bayer Business Overview
    Table 48. Bayer Radioimmunotherapy Product
    Table 49. Bayer Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 50. Bayer Recent Development
    Table 51. Novartis Company Detail
    Table 52. Novartis Business Overview
    Table 53. Novartis Radioimmunotherapy Product
    Table 54. Novartis Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 55. Novartis Recent Development
    Table 56. Lantheus Company Detail
    Table 57. Lantheus Business Overview
    Table 58. Lantheus Radioimmunotherapy Product
    Table 59. Lantheus Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 60. Lantheus Recent Development
    Table 61. Aurobindo Pharma Company Detail
    Table 62. Aurobindo Pharma Business Overview
    Table 63. Aurobindo Pharma Radioimmunotherapy Product
    Table 64. Aurobindo Pharma Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 65. Aurobindo Pharma Recent Development
    Table 66. Mundipharma Company Detail
    Table 67. Mundipharma Business Overview
    Table 68. Mundipharma Radioimmunotherapy Product
    Table 69. Mundipharma Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 70. Mundipharma Recent Development
    Table 71. China Isotope & Radiation Company Detail
    Table 72. China Isotope & Radiation Business Overview
    Table 73. China Isotope & Radiation Radioimmunotherapy Product
    Table 74. China Isotope & Radiation Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 75. China Isotope & Radiation Recent Development
    Table 76. Curium Pharmaceuticals Company Detail
    Table 77. Curium Pharmaceuticals Business Overview
    Table 78. Curium Pharmaceuticals Radioimmunotherapy Product
    Table 79. Curium Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 80. Curium Pharmaceuticals Recent Development
    Table 81. Gilead Sciences Company Detail
    Table 82. Gilead Sciences Business Overview
    Table 83. Gilead Sciences Radioimmunotherapy Product
    Table 84. Gilead Sciences Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 85. Gilead Sciences Recent Development
    Table 86. Clarity Pharmaceuticals Company Detail
    Table 87. Clarity Pharmaceuticals Business Overview
    Table 88. Clarity Pharmaceuticals Radioimmunotherapy Product
    Table 89. Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 90. Clarity Pharmaceuticals Recent Development
    Table 91. Curasight Company Detail
    Table 92. Curasight Business Overview
    Table 93. Curasight Radioimmunotherapy Product
    Table 94. Curasight Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 95. Curasight Recent Development
    Table 96. Nordic Nanovector Company Detail
    Table 97. Nordic Nanovector Business Overview
    Table 98. Nordic Nanovector Radioimmunotherapy Product
    Table 99. Nordic Nanovector Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 100. Nordic Nanovector Recent Development
    Table 101. Philogen Company Detail
    Table 102. Philogen Business Overview
    Table 103. Philogen Radioimmunotherapy Product
    Table 104. Philogen Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 105. Philogen Recent Development
    Table 106. RadioMedix Company Detail
    Table 107. RadioMedix Business Overview
    Table 108. RadioMedix Radioimmunotherapy Product
    Table 109. RadioMedix Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 110. RadioMedix Recent Development
    Table 111. Telix Pharmaceuticals Company Detail
    Table 112. Telix Pharmaceuticals Business Overview
    Table 113. Telix Pharmaceuticals Radioimmunotherapy Product
    Table 114. Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 115. Telix Pharmaceuticals Recent Development
    Table 116. Orano Med Company Detail
    Table 117. Orano Med Business Overview
    Table 118. Orano Med Radioimmunotherapy Product
    Table 119. Orano Med Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 120. Orano Med Recent Development
    Table 121. Actinium Pharmaceuticals Company Detail
    Table 122. Actinium Pharmaceuticals Business Overview
    Table 123. Actinium Pharmaceuticals Radioimmunotherapy Product
    Table 124. Actinium Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 125. Actinium Pharmaceuticals Recent Development
    Table 126. Y-mAbs Therapeutics Company Detail
    Table 127. Y-mAbs Therapeutics Business Overview
    Table 128. Y-mAbs Therapeutics Radioimmunotherapy Product
    Table 129. Y-mAbs Therapeutics Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 130. Y-mAbs Therapeutics Recent Development
    Table 131. Fusion Pharmaceuticals Company Detail
    Table 132. Fusion Pharmaceuticals Business Overview
    Table 133. Fusion Pharmaceuticals Radioimmunotherapy Product
    Table 134. Fusion Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million)
    Table 135. Fusion Pharmaceuticals Recent Development
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Radioimmunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Radioimmunotherapy Market Share by Type: 2023 VS 2030
    Figure 3. Beta-emitting Features
    Figure 4. Targeted Alpha Therapy Features
    Figure 5. Global Radioimmunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Radioimmunotherapy Market Share by Application: 2023 VS 2030
    Figure 7. Solid Tumor Case Studies
    Figure 8. Non Hodgkin Lymphoma Case Studies
    Figure 9. Radioimmunotherapy Report Years Considered
    Figure 10. Global Radioimmunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Radioimmunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Radioimmunotherapy Market Share by Region: 2023 VS 2030
    Figure 13. Global Radioimmunotherapy Market Share by Players in 2023
    Figure 14. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Radioimmunotherapy Revenue in 2023
    Figure 16. North America Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Radioimmunotherapy Market Share by Country (2019-2030)
    Figure 18. United States Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. Canada Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Europe Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Radioimmunotherapy Market Share by Country (2019-2030)
    Figure 22. Germany Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. France Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. U.K. Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Italy Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Russia Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Nordic Countries Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Asia-Pacific Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Radioimmunotherapy Market Share by Region (2019-2030)
    Figure 30. China Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Japan Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. South Korea Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Southeast Asia Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. India Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Australia Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Latin America Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Radioimmunotherapy Market Share by Country (2019-2030)
    Figure 38. Mexico Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Brazil Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Radioimmunotherapy Market Share by Country (2019-2030)
    Figure 42. Turkey Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Saudi Arabia Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Bayer Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 45. Novartis Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 46. Lantheus Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 47. Aurobindo Pharma Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 48. Mundipharma Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 49. China Isotope & Radiation Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 50. Curium Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 51. Gilead Sciences Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 52. Clarity Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 53. Curasight Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 54. Nordic Nanovector Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 55. Philogen Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 56. RadioMedix Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 57. Telix Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 58. Orano Med Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 59. Actinium Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 60. Y-mAbs Therapeutics Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 61. Fusion Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed